RSC Advances
Page 4 of 13
DOI: 10.1039/C4RA14557G
min. The sample is characterised by Xꢀray diffraction (XRD) and
scanning electron microscopy (SEM). Size of prepared SnO 50 1-phenyl pyridine-2,3,5-tricarboxylate (5b)white solid; m.p.
5-ethyl 2,3-dimethyl 6-amino-4-(4-chlorophenyl)-1,4-dihydro-
nanoparticles in the presence of microwave was reduced until 28
nm.
129ꢀ130 oC; IR (KBr): νmax 3426, 3278, 2951, 1749, 1714, 1657,
1597, 1503cmꢀ1; 1H NMR (400 MHz, CDCl3) δ 1.20 (t, J =
6.8Hz, 3H, CH3), 3.41 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 4.05
(q, J = 6.8Hz, 2H, CH2), 4.98 (s, 1H, CH), 6.24 (brs, 2H, NH2),
55 7.26 (m, 2H, ArH), 7.33ꢀ7.38 (m, 2H, ArH), 7.51 (m, 5H, ArH)
ppm; 13C NMR (100MHz, CDCl3) δ 169.4, 166.0, 163.9, 151.2,
145.6, 141.5, 135.2, 131.8, 130.5, 130.4, 129.9, 129.3, 128.2,
107.2, 79.8, 59.4, 52.4, 51.9, 36.6, 14.5 ppm; Anal.Calcd.For
C24H23ClN2O6: C, 61.21; H, 4.92; N, 5.95.Found C, 61.38; H,
60 4.85; N, 5.87.
5
3.7. Preparation of CeO2 nanoparticles
Nano CeO2was prepared according to the procedure reported
in the literatures with some modification.43 CeO2 nanoparticles
were prepared by a coꢀprecipitation technique with postꢀ
annealing in air. Briefly, 3 g of highly pure Ce(NO3)3.6H2O was
10 dissolved in the mixture of 50 ml deionised water and 20 ml
alcohol. Then, the appropriate amount of aqueous ammonia
solution (28 wt%) was added to the above solution till the pH
value reached 8. Where after, the mixture was stirred for 4 h at
room temperature and then dried at 80°C for 6 h. After, the solid
15 was treated at 700°C for 2 h to obtain the CeO2 nanoparticles. The
pattern agrees well with the reported pattern for CeO2
nanoparticles (JCPDS No. 43ꢀ1002). The crystalline size was
calculated from FWHM using Scherrer’s formula and was
observed to be 11 nm.
5-ethyl 2,3-dimethyl 6-amino-4-(4-chlorophenyl)-1,4-dihydro-
1-m-tolylpyridine-2,3,5-tricarboxylate (5c)white solid; m.p.
o
152ꢀ153 C; IR (KBr): νmax 3453, 3275, 2978, 2947, 1734, 1710,
1664, 1596, 1500cmꢀ1; 1H NMR (400 MHz, CDCl3) δ 1.21 (t, J =
65 6.6Hz, 3H, CH3), 2.41 (s, 3H, CH3), 3.43 (s, 3H, OCH3), 3.63 (s,
3H, OCH3), 4.06 (q, J = 6.6Hz, 2H, CH2), 4.97 (s, 1H, CH), 6.25
(brs, 2H, NH2), 7.26ꢀ7.33 (m, 8H, ArH)ppm; 13C NMR
(100MHz, CDCl3) δ 169.4, 166.1, 163.8, 151.3, 145.7, 141.6,
140.2, 135.1, 131.8, 131.1, 130.9, 129.6, 129.3, 128.2, 127.3,
70 107.1, 79.2, 59.4, 52.4, 61.8, 36.7, 21.2, 14.4 ppm;
Anal.Calcd.For C25H25ClN2O6: C, 61.92; H, 5.20; N, 5.78.Found
C, 61.88; H, 5.16; N, 5.81.
20 3.8. General procedure for the preparation of 5-ethyl
2,3-dimethyl
6-amino-1-phenyl-1,4-dihydro-4-phenyl
pyridine-2,3,5-tricarboxylate derivatives:
5-ethyl
2,3-dimethyl
6-amino-1,4-dihydro-1,4-diphenyl
A mixture of aldehyde (2 mmol), ethyl cyanoacetate (2 mmol)
and 4 mol% of CeO2 NPs were stirred in 3 mL ethanol at room
25 temperature for 30 minutes. Then, a solution of dimethyl
acetylenedicarboxylate (2 mmol) and aromatic amine (2 mmol) in
2 mL ethanol was added to it. The whole solution was stirred at
room temperature within 140ꢀ160 minutes (Table 2). The reaction
was monitored by TLC. After completion of the reaction, the
30 solvent was concentrated and the reaction mixture was
diluted in CHCl3; the catalyst was isolated by centrifuging
and the heterogeneous catalyst was recovered. The CHCl3 was
evaporated and the solid separated out was filtered and was
washed with ethanol to get pure product. The structures of the
o
pyridine-2,3,5-tricarboxylate (5d)white solid; m.p. 136ꢀ140 C;
75 IR (KBr): νmax3378, 3269, 2955, 1744, 1713, 1656, 1595, 1492
1
cmꢀ1; H NMR (400 MHz, CDCl3) δ 1.21 (t, J= 6Hz, 3H, CH3),
3.43 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 4.06 (q, J = 6Hz, 2H,
CH2), 5.02 (s, 1H, CH), 6.23 (brs, 2H, NH2), 7.19 (m, 1H, ArH),
7.29(m, 3H, Ar), 7.42(m, 3H, ArH), 7.52(m, 3H, ArH) ppm; 13C
80 NMR (100MHz, CDCl3) δ 169.6, 166.3, 164.1, 151.3, 147.0,
141.4, 135.4, 130.5, 130.3, 129.8, 128.1, 127.8, 126.3, 107.7,
80.3, 59.4, 52.4, 51.8, 37.1, 14.4 ppm; Anal.Calcd.For
C24H24N2O6: C, 66.04; H, 5.54; N, 6.42.Found C, 66.12; H, 5.47;
N, 6.51.
35 products were fully established on the basis of their 1H NMR, 13
NMR and FTꢀIR spectra.
C
85 5-ethyl 2,3-dimethyl 6-amino-4-(4-bromophenyl)-1,4-dihydro-
1-phenylpyridine-2,3,5-tricarboxylate (5e) white solid; m.p.
138ꢀ141oC; IR (KBr): νmax 3490, 3292, 2951, 1739, 1712, 1662,
1602, 1497cmꢀ1; 1H NMR (400 MHz, CDCl3) δ 1.23 (t, J=
6.8Hz, 3H, CH3), 3.41 (s, 3H, OCH3), 3.64 (s, 3H, OCH3), 4.08
90 (q, J = 6.8Hz, 2H, CH2), 4.98 (s, 1H, CH), 6.24 (brs, 2H, NH2),
7.29 (m , 2H, ArH), 7.41 (m, 4H, ArH), 7.51 (m, 3H, ArH) ppm;
13C NMR (100MHz, CDCl3) δ 169.4, 165.9, 163.9, 150.9, 145.9,
141.3, 136.7, 133.8, 131.9, 131.2, 130.3, 129.6, 120.2, 107.6,
80.2, 59.6, 52.6, 52.0, 36.7, 14.4 ppm; Anal.Calcd.For
95 C24H23BrN2O6: C, 55.93; H, 4.50; N, 5.44.Found C, 55.82; H,
4.41; N, 5.50.
3.9.Spectral data
5-ethyl 2,3-dimethyl 6-amino-1-(4-chlorophenyl)-1,4-dihydro-
4-phenyl pyridine-2,3,5-tricarboxylate (5a) white solid; m.p.
o
40 185ꢀ186 C; IR (KBr): νmax 3380, 3269, 2953, 1745, 1712, 1653,
1
1490 cmꢀ1; H NMR (400 MHz, CDCl3) δ 1.24 (t, J = 6Hz, 3H,
CH3), 3.48 (s, 3H, OCH3), 3.64 (s, 3H, OCH3), 4.10 (q, J= 6Hz,
2H, CH2,), 5.01 (s, 1H, CH), 6.17 (brs, 2H, NH2), 7.20 ( 1H,
ArH), 7.27 ( 5H, ArH), 7.47 ( 3H, ArH) ppm; 13C NMR
45 (100MHz, CDCl3) δ 169.5, 166.1, 164.0, 150.9, 146.7, 141.0,
136.4, 134.0, 131.9, 130.1, 128.1, 127.8, 126.4, 108.2, 80.6, 59.5,
52.6, 51.9, 37.0, 14.4 ppm; Anal.Calcd.For C24H23ClN2O6: C,
61.21; H, 4.92; N, 5.95.Found C, 61.39; H, 4.82; N, 5.85.
5-ethyl 2,3-dimethyl 6-amino-1-(4-chlorophenyl)-1,4-dihydro-
4-(4-methoxy phenyl)pyridine-2,3,5-tricarboxylate (5f) white
o
solid; m.p. 181ꢀ182 C; IR (KBr): νmax 3390, 3274, 2950, 1742,
100 1712, 1655, 1608, 1500 cmꢀ1; H NMR (400 MHz, CDCl3) δ
1
1.23 (t, J = 6.8Hz, 3H, CH3), 3.46 (s, 3H, OCH3), 3.63 (s, 3H,
4
|Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]